Polyneuron Pharamceuticals AG’s To Extend To CHF 36.5 Million Its Series A Financing Round

Paolo Bossi

VISCHER advised Polyneuron Pharmaceuticals AG in the extention of its Series A by CHF 14m bringing the total to CHF 36.5m. Polyneuron is a clinical stage…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here